Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-21-002484

Options or other derivatives

  • CEO and President acquired 800,075 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Violin Jonathan CEO and President 2021-01-18 Grant or award · Employee Stock Option (right to buy) +800,075 800,075 D
Loading xslF345X03/doc4.xml…